Nucleic Acid Extraction Kit Market

Nucleic Acid Extraction Kit Market Outlook from 2024 to 2034

Exhibiting a Y-o-Y growth of 8.1%, the global nucleic acid extraction kit market size is projected to reach USD 2,134.40 million in 2024. It will likely register rapid growth, with global nucleic acid extraction kit demand rising at a CAGR of 7.4%. By 2034, the global market valuation is set to total USD 4,285.08 million.

DNA extraction kits remain highly sought-after products because of their rising usage in applications like genetic testing and disease diagnostics. As per the latest analysis, the target segment is estimated to account for a value share of 49.1% in 2024.

The adoption of nucleic acid kits is revolutionizing disease diagnosis globally. This is due to their ability to detect pathogens and genetic abnormalities rapidly and specifically. As a result, the target market is set to expand 2.0X through 2034.

Nucleic Acid Extraction Kit Market Insights:

Attributes	Key Insights
Base Market Value (2023)	USD 1,974.90 million
Estimated Nucleic Acid Extraction Kit Market Value (2024)	USD 2,134.40 million
Projected Nucleic Acid Extraction Kit Market Revenue (2034)	USD 4,285.08 million
Value CAGR (2024 to 2034)	7.4%

Nucleic Acid Extraction Kit Market Overview

• Nucleic acid extraction (NAE) has become a critical step in molecular biology. It is used in many areas of the biological and medical sciences. Rising importance of this process in molecular diagnostics and other applications is putting the nucleic acid extraction kit market into the spotlight.
• Nucleic acid extraction kits make it simple to extract genome, plasmid, and RNA from samples. They help in obtaining biological information in fields ranging from specimen identification for conservation to personalized medicine and pharmacogenomics.
• Growing adoption of nucleic acid extraction kits in molecular biology research is expected to boost sales. These kits have become essential for techniques like next-generation sequencing (NSG), polymerase chain reaction (PCR), and sanger sequencing.

Top Factors Driving Growth of Nucleic Acid Extraction Kit Market include

• Rising prevalence of chronic and infectious diseases, coupled with growing demand for molecular diagnostics
• Growing emphasis on early and precise diagnosis for better disease management
• Increasing importance of nucleic acid extraction in pharmaceutical and biotechnology sector for applications like drug discovery and genetic engineering
• Expanding usage of nucleic acid extraction kits in diagnostic centers and hospitals for routine testing as well as specialized testing like cancer diagnosis and genetic testing
• Increasing awareness of genetic diseases, especially across developing nations like India and China
• Rising investments in cancer research
• Growing usage of nucleic acid extraction kits in forensic analysis and environmental monitoring
• Surging demand for genetic material processing kits

Global Nucleic Acid Extraction Kit Market Trends

• Increasing adoption of automation in nucleic acid extraction
• Rising demand for personalized medicine
• Growing interest in preventive healthcare
• Ongoing technological advancements in nucleic acid extraction kits, including miniaturization and automation
• Surging popularity of point-of-care (POCT) testing, along with rising demand for POCT devices that rely on nucleic acid extraction

Historical Performance Vs Future Nucleic Acid Extraction Kit Market Forecast

Global sales of nucleic acid extraction kits recorded a CAGR of 6.1% from 2019 to 2023. The nucleic acid extraction kit market accounted for around 16.3% of the global molecular diagnostics kit market, valued at USD 11,134.3 million.

Over the forecast period, the global nucleic acid extraction kit industry is set to expand at 7.1% CAGR. It will likely total a valuation of USD 4,285.08 million by 2034, driven by factors like rising prevalence of chronic disease and growing demand for molecular diagnostics.

• The rising incidence of cancer globally is resulting in the need for advanced RNA and DNA extraction kits. This, in turn, is expected to drive growth of the nucleic acid extraction kit market in the upcoming years.
• RNA and DNA extraction plays an important role in cancer genetic research. It involves mutation analysis, comparative genomic hybridization, and microsatellite analysis. Thus, rising cancer cases globally and increasing investment in cancer research will likely uplift nucleic acid extraction kit demand.
• In medical settings, there is an increasing need to handle larger amounts of plasma efficiently to reduce costs and produce concentrated samples for subsequent diagnostic analyses like NSG. This will likely boost sales of nucleic acid extraction kits through 2034.
• The development of tailored small molecule and antibody-based medicines has accelerated the adoption of genomic tests in cancer patients. By identifying individual targetable mutations, genomic approaches can estimate mutational burden. This can be used to predict therapeutic response to immune-checkpoint inhibitors or to identify cancer-specific proteins to create tailored anticancer vaccines.
• Growing demand for genetic material extraction kits is anticipated to foster growth of the nucleic acid extraction kit market through 2034. Similarly, high adoption of nucleic acid isolation kits in medical applications will support market expansion.

Insights into Opportunities in the Nucleic Acid Extraction Kit Market

In the past few years, government agencies in the Asia-Pacific and Middle East regions have effectively motivated manufacturers to contribute to the expansion of the healthcare and biopharmacy sectors. Major companies have the opportunity to capitalize on this encouragement to enhance their standing in the market.

Countries in the Asia-Pacific region, particularly developing ones like India, have removed export restrictions on diagnostic kits and reagents. This includes equipment like nucleic acid extraction kits and systems used for detecting coronavirus infections.

Country-wise Insights

The below table shows the estimated growth rates of the top countries. China, India, and the United Kingdom are set to record higher CAGRs of 13.0%, 8.5%, and 8.6% respectively, through 2034.

Market Growth Outlook by Key Countries

Countries	Projected Nucleic Acid Extraction Kit Market CAGR
United States	4.1%
Germany	6.0%
United Kingdom	8.6%
Japan	7.9%
China	13.0%
India	8.5%

Rising Demand for Personalized Medicine Boosting the United States Market

The United States nucleic acid extraction kit market is estimated to be valued at USD 634.06 million in 2024. It will likely exhibit steady growth, with overall demand for nucleic acid extraction kits rising at 4.1% CAGR through 2034. This can be attributed to factors like:

• Rising cases of diabetes, cancer, and other chronic diseases
• Increasing investments in life science research, including genome projects
• Surging popularity of personalized medicine
• High adoption of automated nucleic acid extraction systems
• Growing importance of nucleic acid extraction in thriving pharmaceutical and biopharmaceutical industries
• Integration of nucleic acid extraction with molecular diagnostic technologies like sequencing and PCR

The United States is a frontrunner in the nucleic acid extraction kit market due to several factors. Firstly, the nation boasts a robust research infrastructure with well-established laboratories and academic institutions that conduct extensive genomic research.

Institutions such as the National Institutes of Health (NIH) and leading universities contribute significantly to the demand for nucleic acid extraction kits. Similarly, rising trend of personalized medicine will likely propel nucleic acid extraction kits demand in the nation.

The United States has a well-established healthcare system that emphasizes precision medicine and personalized treatments. This will continue to create a steady demand for nucleic acid extraction kits in clinical diagnostics and research.

China to Become a Happy Hunting Ground for Manufacturers

China is anticipated to emerge as the hotbed for nucleic acid extraction kit manufacturers during the forecast period. The latest report predicts China nucleic acid extraction kit market to thrive at 13.0% CAGR during the forecast period. Some of the key drivers/trends include:

• Growing incidence of chronic and infectious diseases
• Rising investments in research and development across fields like molecular diagnostics
• Increasing government support for the healthcare and medical devices industries

China's expansion in the nucleic acid extraction kit market is notable, driven by advancements in biotechnology and molecular diagnostics. The country's robust investment in research and development, coupled with a burgeoning healthcare sector, is propelling demand for nucleic acid extraction kits.

Growing awareness and adoption of molecular testing techniques in various applications, including academic research and clinical diagnostics, contribute to rapid market growth. Subsequently, development of innovative nucleic acid kits is set to support market expansion.

Expanding Healthcare Industry Influencing Sales in India

Sales of nucleic acid extraction kits in India are poised to grow at a CAGR of 8.5% throughout the forecast period. Accordingly, the nucleic acid extraction kit market in India is estimated to be valued at USD 102.05 million, driven by factors like:

• Expanding healthcare industries, coupled with growing health awareness
• Rising prevalence of genetic disorders and cancer
• Growing demand for genomic DNA extraction kits
• Increasing government investments in improving healthcare infrastructure and promoting research activities
• Growing emphasis on preventive healthcare

India is making significant strides in the nucleic acid extraction kit market, showcasing positive growth trends. The nation's advancements in biotechnology and molecular research are contributing to a notable improvement in this sector.

Increasing investment in research and development, coupled with a growing emphasis on healthcare infrastructure, are set to boost market growth in India. The nation is poised to make valuable contributions to the field, reflecting its commitment to advancing biotechnological capabilities and fostering innovation in nucleic acid extraction technologies.

Category-wise Insights

The table section offers detailed insights into top segments in the nucleic acid extraction kit industry. This information will likely allow players to frame their strategies accordingly to boost revenue and stay ahead of the competition.

• The DNA extraction kits segment is expected to account for a prominent revenue share of 49.1% in 2024.
• By sample type, the biological samples category will likely hold a market share of 45.2% in 2024.
• Based on target type, the bacterial segment is poised to account for a value share of 31.5% in 2024.
• By format, the 96-well plate segment will likely total USD 808.19 million in 2024.
• Based on purpose, the research use only segment is anticipated to account for a value share of 65.3% in 2024
• By application, the disease diagnosis segment is predicted to generate revenue worth USD 482.28 million by 2024.
• In terms of end use, the diagnostic laboratories segment is forecast to have a market share of 24.4% in 2024.

Demand Remains High for DNA Extraction Kits in the Market

Market Growth Outlook by Key Products

Products	Value CAGR
DNA Extraction Kits	6.2%
Radial Closure Devices	8.0%
Total Nucleic Acid (RNA + DNA)	9.6%

As per the latest analysis, the DNA extraction kits segment is expected to dominate the global market, holding a revenue share of 49.1% in 2024. Over the forecast period, demand for DNA extraction kits is set to increase at 6.2% CAGR.

• DNA extraction kit demand is high because they save time, ensure reproducibility, and are user-friendly. These advantages are making them a preferred choice for scientists working on DNA-related applications.
• DNA extraction kits offer a convenient and efficient way to isolate DNA from various samples. These kits provide ready-to-use reagents and simplified protocols, making the extraction process quicker and more accessible for researchers.
• Rising importance of DNA analysis in applications like genetic testing, personalized medicine, and disease diagnostics will likely propel DNA extraction kit demand.
• To gain maximum benefits, key players are focusing on developing new DNA extraction kits with enhanced efficiency, purity, and yield of extracted DNA.

Biological Samples Segment to Account for a Market Share of 45.2% in 2024

Market Growth Outlook by Key Samples

Sample Type	Value CAGR
Biological Samples	5.4%
Environmental Samples	7.0%
Insect	9.8%
Plant	7.1%
Gel (e.g. agarose)	8.5%
PCR Clean-up (post-PCR amplification product extraction)	12.1%

Based on sample type, the biological samples segment is poised to grow at 5.4% CAGR during the assessment period. It will likely hold a market share of 45.2% in 2024.

• Biological samples are prominent in the nucleic acid extraction kit market because they provide genetic material like DNA or RNA for analysis. These samples, often from tissues or cells, are crucial for understanding diseases and developing treatments.
• Growing adoption of biological samples in routine clinical care for diagnosis, prognosis, and monitoring is expected to boost the target segment.
• Researchers often use biological samples to extract genetic material efficiently, aiding in various applications such as diagnostics and research.

Bacterial Segment Set to Take a Bigger Piece of Pie

Market Growth Outlook by Key Target Type

Target Type	Value CAGR
Bacterial	5.6%
Viral	7.0%
Bacterial & Viral	7.9%
Fungi	8.6%
Spores	9.8%
Other Target types	10.7%

The bacterial segment is expected to retain its market dominance, holding a market share of 31.5% in 2024. Further, it will likely record a CAGR of 5.6% throughout the assessment period.

• Extracting genetic material (nucleic acids) from bacteria helps scientists study and understand them better. This is essential for tasks like diagnosing diseases, developing treatments, and advancing scientific knowledge.
• Rising need for bacterial nucleic acid extraction in microbiology and molecular biology is expected to foster segment growth.
• Increasing incidence of bacterial infections is creating a higher demand for diagnostic tools that require reliable bacterial DNA extraction. This will further boost the target segment.

96-well Plate Becoming Popular Format

Market Growth Outlook by Key Format

Format	Value CAGR
Columns	9.5%
96-Well Plate	5.4%
Magnetic Beads (Automatable)	7.1%
Other Format	10.0%

Based on format, the 96-well plate segment is set to lead the global market, with a share of 37.9% in 2024. It will also exhibit a CAGR of 5.4% between 2024 and 2034.

• Rising usage of 96-well plates for nucleic acid extraction due to advantages like increased throughput and cost-effectiveness is driving segment growth.
• 96 well plate wells significantly increase the throughput and save time and resources. Researchers can extract DNA or RNA from many samples in one go, making the process more streamlined and cost-effective.
• The 96-well plate format is widely adopted for its convenience and effectiveness in high-throughput applications, contributing to its leading position in the market.
• 96-well plates are becoming ideal for large-scale studies like drug discovery, genomic research, and clinical diagnostics. This is because these high-scale studies often involve analyzing numerous samples.
• Development of novel 96-well culture plates by companies like Thermo Fisher Scientific will likely boost segment growth.

Usage of Nucleic Acid Extraction Kits Remains High for Research Purposes

Market Growth Outlook by Key Purpose

Purpose	Value CAGR
Research Use Only (RUO)	6.4%
Clinical Use	9.2%

As per the latest report, nucleic acid extraction kit consumption remains high in research projects. The target segment will likely grow at 6.4% CAGR during the forecast period, holding a value share of 65.3% in 2024.

• Research use only (RUO) is set to dominate the nucleic acid extraction kit market through 2034. This is because these kits are primarily designed and intended for research purposes.
• Nucleic extraction kits provide scientists and researchers with reliable tools to extract genetic material like DNA and RNA from samples. As a result, they are witnessing higher demand from the research sector.
• As the demand for genetic research and studies increases, sales of products like nucleic acid extraction kits will grow significantly. This, in turn, is expected to foster segment growth during the forecast period.

Disease Diagnosis Remains the Most Remunerative Application

Market Growth Outlook by Key Application

Application	Value CAGR
Disease Diagnosis	4.6%
Drug Diagnosis	6.4%
Cancer Research	7.1%
cDNA library	7.8%
Environmental DNA (eDNA) Studies	8.7%
Food Safety Testing	9.7%
GMO Detection	10.0%
Other Applications	11.0%
Disease Diagnosis	4.6%

Based on application, the disease diagnosis segment is projected to generate significant revenue for the market. As per the latest analysis, the target segment will likely progress at 4.6% CAGR during the forecast period, totaling revenue worth USD 482.28 million in 2024.

• Nucleic acid extraction kits are mostly used in disease diagnosis applications. They help in extracting genetic material from samples, like blood or saliva. This genetic material contains information about diseases, allowing doctors to identify and diagnose illnesses.
• Growing prevalence of chronic diseases is expected to boost growth of the target segment. This is because nucleic acid extraction kits are often used to monitor disease progression and develop targeted therapies.
• Rising focus on early and precise diagnosis for effective disease management will likely uplift nucleic acid extraction kit demand through 2034.

Diagnostic Laboratories Remain Leading End Users

Market Growth Outlook by Key End User

End User	Value CAGR
Hospitals	5.4%
Academic & Research Institutes	9.4%
Pharmaceutical & Biotechnology Companies	8.4%
Clinical Research Organizations	6.4%
Diagnostic Laboratories	4.6%
Forensic Labs	10.5%
Food Testing Laboratories	10.1%
Agricultural and Environmental Research Institutes	12.3%

Diagnostic laboratories are expected to remain leading end users of nucleic acid extraction kits during the forecast period. The target segment will likely exhibit a 4.6% CAGR, holding a market share of 24.4% in 2024.

• Diagnostic laboratories are at the forefront of the nucleic acid extraction kit industry. This is because they heavily rely on these kits for extracting genetic material, like DNA or RNA.
• Diagnostic labs play a crucial role in medical testing and diagnostics. They often seek advanced nucleic acid extraction kits for advancing diagnostic technologies like real-time PCR to ensure accurate and efficient results.
• The demand for accurate and reliable nucleic acid extraction is high in diagnostic processes. This is making these kits essential for identifying diseases and conditions.

Competitive Landscape

Key manufacturers of nucleic acid extraction kits are increasingly investing in research and development to advance in nucleic acid extraction technology. They are continuously introducing new kits and other solutions, as well as implementing strategies acquisitions, mergers, and partnerships to stay ahead of the competition.

Recent Developments in the Nucleic Acid Extraction Kit Market

• In December 2023, PerkinElmer acquired Covaris, a leading producer of technologies that enable advancements in life science.
• In 2020, GeneProof introduced the new Geneproof Universal Nucleic Acid Extraction Kit. The new kit is designed for the extraction of bacterial, viral, and human RNA and DNA from one sample at the same time.
• In April 2023, the new Cell Nucleic Acid Extraction Kit and Automated Nucleic Acid Extraction Workstation SAW-14 were launched by BioPerfectus.
• In March 2021, a real-time reverse transcription PCR (qRT-PCR) kit registered with CE-IVD was introduced by Agilent Technologies to detect SARS-CoV-2 RNA.

Key Coverage in the Global Nucleic Acid Extraction Kit Market Research Report

• Adjacent Study on Global Extraction Kits Market, Nucleic Acid Sample Preparation Kit Market, DNA Sequencing Services Market, and Cell-free Fetal DNA Testing Market
• Global Extraction Kits Market Analysis
• Top Manufacturers of Molecular Biology Kits
• Expected DNA/RNA Extraction Market Size
• Factors Propelling Nucleic Acid Extraction System Market Growth
• Detailed Molecular Biology Kit Industry Overview
• Most Popular Biomedical Extraction Kits in the Market
• Ongoing Innovation in Molecular Biology Reagents
• Top Selling Nucleic Acid Purification Kits
• Impact of Global Infectious Disease Burden on Viral Nucleic Acid Isolation Kit Sales
• Latest Advancements in Nucleic Acid Extraction Techniques
• Prices of Commonly Used Products like Qiagen’s DNA Extraction Kits

Nucleic Acid Extraction Kit Industry Report Scope

Attribute	Details
Estimated Market Value (2024)	USD 2,134.40 million
Projected Market Size (2034)	USD 4,285.08 million
Expected Growth Rate (2024 to 2034)	7.4% CAGR
Forecast Period	2024 to 2034
Historical Data Available for	2019 to 2023
Market Analysis	USD Million for Value
Key Regions Covered	North America; Latin America; East Asia; South Asia & Pacific; Western Europe; Eastern Europe; and Middle East & Africa
Key Countries Covered	United States, Canada, Mexico, Brazil, Chile, China, Japan, South Korea, India, ASEAN Countries, Australia & New Zealand, Germany, Italy, France, United Kingdom, Spain, BENELUX, Nordic Countries, Russia, Hungary, Poland, Saudi Arabia, Türkiye, South Africa, Other African Union.
Key Market Segments Covered	Product Type, Sample Type, Target Type, Format, Purpose, Application, End User, and Region
Key Companies Profiled	Bio-Rad Laboratories, Inc.; Thermo Fisher Scientific Inc.; Promega Corporation; Agilent Technologies, Inc.; Merck KGaA; Bioneer Corporation; PerkinElmer Inc.; LGC Biosearch Technologies; QIAGEN; GeneBio Systems, Inc.; Takara Bio Inc.; F. Hoffmann-La Roche Ltd; GeneReach Biotechnology Corp.; Akonni Biosystems, Inc.; Primerdesign Ltd; ProtonDx; GVS S.p.A.; TRIVITRON HEALTHCARE PVT. LTD.; Almanac Life Science India; New England Biolabs.; RBC Bioscience Corp.; Zymo Research Corporation.; Omega Bio-tek, Inc.; Molzym GmbH & Co. KG
Report Coverage	Market Forecast, Competition Intelligence, DROT Analysis, Market Dynamics and Challenges, Strategic Growth Initiatives

Table of Content

• 1. Executive Summary
• 2. Market Overview
• 3. Key Market Trends
• 4. Value-Added Insights
• 5. Market Background
• 6. Global Market Demand (in Volume Units) Analysis 2019 to 2023 and Forecast, 2024 to 2034
• 7. Global Market - Pricing Assessment
• 8. Global Market Demand (in Value or Size in USD million) Analysis 2019 to 2023 and Forecast, 2024 to 2034
• 9. Global Market Analysis 2019 to 2023 and Forecast 2024 to 2034, By Product
  • 9.1. DNA extraction Kits
    • 9.1.1. Sequence-specific DNA
    • 9.1.2. Cell-free DNA (cfDNA)
    • 9.1.3. Tissue DNA Extraction Kits
  • 9.2. RNA extraction Kits
    • 9.2.1. Total RNA
    • 9.2.2. Purified RNAs
    • 9.2.3. Viral RNA
    • 9.2.4. Sequence-specific RNA
  • 9.3. Total nucleic acid (RNA + DNA)
• 10. Global Market Analysis 2019 to 2023 and Forecast 2024 to 2034, By Sample Type
  • 10.1. Biological Samples
    • 10.1.1. Cell-free, or nearly cell-free
      • 10.1.1.1. Swab samples
        • 10.1.1.1.1. Nasal
        • 10.1.1.1.2. Throat
        • 10.1.1.1.3. Nasopharyngeal
        • 10.1.1.1.4. Buccal
        • 10.1.1.1.5. Oral
      • 10.1.1.2. Saliva
      • 10.1.1.3. Urine
      • 10.1.1.4. Serum
      • 10.1.1.5. Plasma
      • 10.1.1.6. Cerebrospinal fluid (CSF)
    • 10.1.2. Tissue
      • 10.1.2.1. Organ (e.g. lung, liver, heart, etc.)
      • 10.1.2.2. Bone
      • 10.1.2.3. Cartilage
      • 10.1.2.4. Skin
      • 10.1.2.5. Tumour biopsy
    • 10.1.3. Blood
      • 10.1.3.1. Whole blood
      • 10.1.3.2. RBC (red blood cells)
      • 10.1.3.3. Plasma
      • 10.1.3.4. Serum
      • 10.1.3.5. Dried blood spots
    • 10.1.4. Sputum
    • 10.1.5. Stool/fecal matter
    • 10.1.6. Cells
    • 10.1.7. Paraffin embedded tissue
  • 10.2. Environmental samples
    • 10.2.1. Soil
    • 10.2.2. Water/wastewater
  • 10.3. Insect
  • 10.4. Plant
  • 10.5. Gel (e.g. agarose)
  • 10.6. PCR Clean-up (post-PCR amplification product extraction)
  • 10.7. Other sample types
• 11. Global Market Analysis 2019 to 2023 and Forecast 2024 to 2034, By Target Type
  • 11.1. Bacterial
  • 11.2. Viral
  • 11.3. Bacterial & Viral
  • 11.4. Fungi
  • 11.5. Spores
  • 11.6. Other
• 12. Global Market Analysis 2019 to 2023 and Forecast 2024 to 2034, By Format
  • 12.1. Columns
  • 12.2. 96-Well Plate
  • 12.3. Magnetic Beads (Automatable)
  • 12.4. Other Format
• 13. Global Market Analysis 2019 to 2023 and Forecast 2024 to 2034, By Purpose
  • 13.1. Research Use Only (RUO)
  • 13.2. Clinical Use
• 14. Global Market Analysis 2019 to 2023 and Forecast 2024 to 2034, By Application
  • 14.1. Disease Diagnosis
  • 14.2. Drug Diagnosis
  • 14.3. Cancer Research
  • 14.4. cDNA library
  • 14.5. Environmental DNA (eDNA) Studies
  • 14.6. Food Safety Testing
  • 14.7. GMO Detection
  • 14.8. Other Applications
• 15. Global Market Analysis 2019 to 2023 and Forecast 2024 to 2034, By End User
  • 15.1. Hospitals
  • 15.2. Academic & Research Institutes
  • 15.3. Pharmaceutical & Biotechnology Companies
  • 15.4. Clinical Research Organizations
  • 15.5. Diagnostic Laboratories
  • 15.6. Forensic Labs
  • 15.7. Food Testing Laboratories
  • 15.8. Agricultural and Environmental Research Institutes
• 16. Global Market Analysis 2019 to 2023 and Forecast 2024 to 2034, By Region
  • 16.1. North America
  • 16.2. Latin America
  • 16.3. East Asia
  • 16.4. South Asia & Pacific
  • 16.5. Western Europe
  • 16.6. Eastern Europe
  • 16.7. Middle East & Africa
• 17. North America Market Analysis 2019 to 2023 and Forecast 2024 to 2034
• 18. Latin America Market Analysis 2019 to 2023 and Forecast 2024 to 2034
• 19. East Asia Market Analysis 2019 to 2023 and Forecast 2024 to 2034
• 20. South Asia & Pacific Market Analysis 2019 to 2023 and Forecast 2024 to 2034
• 21. Western Europe Market Analysis 2019 to 2023 and Forecast 2024 to 2034
• 22. Eastern Europe Market Analysis 2019 to 2023 and Forecast 2024 to 2034
• 23. Middle East & Africa Market Analysis 2019 to 2023 and Forecast 2024 to 2034
• 24. Market Structure Analysis
• 25. Competition Analysis
  • 25.1. Bio-Rad Laboratories, Inc.
  • 25.2. Thermo Fisher Scientific Inc.
  • 25.3. Promega Corporation
  • 25.4. Agilent Technologies, Inc.
  • 25.5. Merck KGaA
  • 25.6. Bioneer Corporation
  • 25.7. PerkinElmer Inc.
  • 25.8. LGC Biosearch Technologies
  • 25.9. QIAGEN
  • 25.10. GeneBio Systems, Inc.
  • 25.11. Takara Bio Inc.
  • 25.12. F. Hoffmann-La Roche Ltd
  • 25.13. GeneReach Biotechnology Corp.
  • 25.14. Akonni Biosystems, Inc.
  • 25.15. Primerdesign Ltd
  • 25.16. ProtonDx
  • 25.17. GVS S.p.A.
  • 25.18. TRIVITRON HEALTHCARE PVT. LTD.
  • 25.19. Almanac Life Science India
  • 25.20. New England Biolabs.
  • 25.21. RBC Bioscience Corp.
  • 25.22. Zymo Research Corporation.
  • 25.23. Omega Bio-tek, Inc.
  • 25.24. Molzym GmbH & Co. KG
• 26. Assumptions and Acronyms Used
• 27. Research Methodology